Malignant melanoma is the most aggressive form of skin cancer and its incidence has doubled in the last two decades. It represents only 4% of skin cancer cases per year, but causes as many as 74% of skin cancer deaths. Early detection of malignant melanoma is associated with survival rates of up to 90%, but later detection (stage III to stage IV) is associated with survival rates of only 10%. Dysregulation of microRNA (miRNA) expression has been linked to tumor development and progression by functioning either as a tumor suppressor, an oncogene or a metastasis regulator in multiple cancer types. To understand the role of miRNA in the pathogenesis of malignant melanoma and identify biomarkers of metastasis, miRNA expression profiles in skin punches from 33 metastatic melanoma patients and 14 normal healthy donors were compared. We identified a cluster of 14 miRNAs on the X chromosome, termed the miR-506-514 cluster, which was consistently overexpressed in nearly all melanomas tested (30-60 fold, Po0.001), regardless of mutations in N-ras or B-raf. Inhibition of the expression of this cluster as a whole, or one of its sub-clusters (Sub-cluster A) consisting of six mature miRNAs, led to significant inhibition of cell growth, induction of apoptosis, decreased invasiveness and decreased colony formation in soft agar across multiple melanoma cell lines. Sub-cluster A of the miR-506-514 cluster was critical for maintaining the cancer phenotype, but the overexpression of the full cluster was necessary for melanocyte transformation. Our results provide new insights into the functional role of this miRNA cluster in melanoma, and suggest new approaches to treat or diagnose this disease.
Introduction
Melanoma is currently the fifth most frequently diagnosed cancer in the United States and is predicted to account for B65% of all skin cancer deaths in 2010 (Rigel et al., 2010) . Melanoma metastases can occur early in the course of disease; therefore, detecting melanoma early is critical for patient survival (Rigel et al., 2010) . Beyond an early surgical removal of the primary tumor, there is currently no highly effective standard therapy available, especially for more advanced stages (Segura et al., 2010) . Additionally, attempts to incorporate molecularly derived prognostic markers have been hindered by high variability and lack of standardization. Without effective treatments, early identification of patients at the highest risk for the development of aggressive/metastatic disease is critical (Segura et al., 2010) .
MicroRNAs (miRNAs) are small non-coding RNAs (Ambros and Lee, 2004) important for a diverse range of biological functions in both normal and pathological settings. Significant data have accumulated showing that dysregulated miRNAs act as oncogenes (onco-miRs) or tumor suppressors (TS-miRs) through their effects on various pathways critical to the cancer phenotype (Landais et al., 2007; Sotiropoulou et al., 2009; Segura et al., 2010) . Multiple studies have characterized these dysregulated miRNAs in diverse cancer types, including melanoma (Lu et al., 2005; Felicetti et al., 2008; Mirnezami et al., 2009; Sotiropoulou et al., 2009) . Evidence also exists that miRNA clusters can have oncogenic properties in cancer, where the role of the miR-17-92 cluster in lymphoma has been the most extensively characterized (Olive et al., 2010) . Relatively few miRNAs altered in melanoma have been evaluated functionally; however, identifying either a diagnostic or therapeutic role for miRNA has the potential to drastically improve the life expectancy for many patients.
In this study, we compared the miRNA expression profiles of skin punches from metastatic melanoma patients, normal healthy donors and primary melanocytes. Results from this study revealed overexpression of a miRNA cluster in melanoma (miR-506-514) , which includes seven distinct miRNAs: miR-506, -507, -508, -509, -510, -513 and miR-514, previously reported to be conserved in primates (Zhang et al., 2007; Li et al., 2010) . Functional analysis highlighted the key involvement of this cluster in regulating cell growth, apoptosis, invasion and soft agar colony formation. Additionally, results indicated that a sub-cluster of the miR-506-514 cluster was critical for maintaining the cancer phenotype, but overexpression of the full cluster was required for melanocyte transformation. To our knowledge, this is the first report on the importance of this cluster in the development of melanoma or any other cancer type. Characterizing the functional role of this cluster could lead to the identification of new targets and/or biomarkers that could positively impact melanoma patients.
Results
Overexpression of the miR-506-514 cluster in melanoma patient biopsies and cell lines Dysregulation of miRNA expression has been linked to tumor development and progression, but few miRNAs associated with melanoma tumorigenesis have been functionally characterized. We measured miRNA expression profiles in skin punches from 33 melanoma patients (all patient information shown in Supplementary Table 1 ), 14 normal donors, primary melanocytes from four donors and a panel of five melanoma cell lines (SKMEL-2, SKMEL-5, A375, MALME-3M and RPMI-7951) to identify miRNAs potentially involved in the development and progression of this disease. All samples were initially profiled by miRNA TaqMan Low-density Array (TLDA) to determine overall expression changes and results were confirmed on the Biomark dynamic array microfluidic platform. Cluster analysis of gene expression profiles revealed a spectrum of melanomas that was distinct from normal skin and melanocytes ( Figure 1a ). The majority of melanoma samples (23/33) clustered together and substantially overexpressed all mature miRNAs of the miR-506-514 cluster. A second set of melanoma samples (10/33) had more modest overexpression of these miRs and clustered together with melanoma cell lines. In contrast, normal skin and melanocytes with significant underexpression of this set of miRNAs formed a separate and distinct cluster. Neither demographic variables and stage of disease nor mutations in B-raf or N-ras were associated with differences in gene expression profiles among melanoma samples and clusters (Supplementary Table 1 ).
The miR-506-514 cluster was significantly overexpressed in melanoma tissue and five melanoma cell lines compared with melanocytes and normal skin by an average of 30-60-fold and 4-20-fold, respectively (Po0.001, Figures 1b and c) . The overexpression of the miR-506-514 cluster in these cell lines and the observation that they cluster together with melanoma tissue suggest that these cell lines are a relevant in vitro model. For this reason, we used these cell lines to characterize the impact of the miR-506-514 cluster on the functional aspects of melanoma.
Inhibition of the miR-506-514 cluster significantly inhibited melanoma cell growth and invasion/migration To characterize the function of miR-506-514 in melanoma progression, all members of this cluster were inhibited simultaneously in five melanoma cell lines using commercially available RNA hairpin inhibitors at 10 nM each (70 nM total). We consistently achieved 80-85% transfection efficiency in both cell lines and primary melanocytes, as determined by fluorescently labeled miRNA controls. This similarity in transfection efficiency allowed us to directly compare functional differences between normal and melanoma cells. Cell growth was measured 3 and 5 days posttransfection and compared with cells transfected with miRNA non-targeting inhibitor. Growth of five melanoma cell lines was reduced 25-35% following inhibition of the miR-506-514 cluster, whereas normal melanocytes showed only a 12% decrease (Figure 2a ). The degree of growth inhibition was significantly different (Po0.001) in melanoma cell lines when compared with normal melanocytes, suggesting that the overexpression of the miR-506-514 cluster is important for maintaining melanoma cell growth.
In addition to growth, the ability of cells to migrate and/or invade is a process critical to cancer progression and metastasis. Of the cell lines used to examine growth, the MALME-3M and A375 cells invaded and migrated to greater levels and were therefore chosen for subsequent assays. Following inhibition of the miR-506-514 cluster in MALME-3M cells, migration and invasion were both decreased B50% at 24 h when compared with cells transfected with a control non-targeting inhibitor (Figure 2b ). Similar results were observed in A375 cells, with a 50% and 35% reduction in migration and invasion, respectively (Figure 2b ). This reduction following inhibition of the miRNA cluster was evident even at 6 h post-transfection at which time there was little apoptosis observed (see below), indicating that the effect on migration and invasion was not merely due to apoptosis.
Inhibition of the miR-506-514 cluster significantly increased melanoma cell apoptosis Decreased cancer cell growth can result from growth arrest, increased apoptosis or a combination of both. Given the ability of cancer cells to acquire compensatory mutations and develop resistance to treatments with only cytostatic effects, increasing melanoma cell death may have a significant impact on the success of any potential therapeutic intervention. Accordingly, we measured apoptosis using caspase 3/7 activation and Annexin V/propidium iodide (PI) flow cytometry in A375, SKMEL-5 and MALME-3M melanoma cell lines following inhibition of the full miR-506-514 cluster by their cognate hairpin inhibitors. Results showed that activation of caspase 3/7, an early indicator of apoptosis, was increased by 50-75% in transfected cell lines at 48 h post-transfection, compared with cells transfected with non-targeting miRNA controls (Figure 3a ). Timepoints before 48 h (8 and 24 h) did not show significant changes in caspase induction (data not shown). The Annexin V flow cytometry assay measures the levels of phosphatidylserine present on the cell surface, which indicates apoptotic progression. The complete loss of membrane integrity is not seen until the final stages of cell death, so uptake of the vital dye PI distinguishes between early apoptotic cells (Annexin V positive/PI negative) and late apoptotic cells (Annexin V positive/PI positive). Inhibition of the miR-506-514 cluster in A375, SKMEL-5 and MALME-3M cells significantly increased the percentage of total apoptotic cells (both early and late) to 56, 54, and 56%, respectively, compared with 15-19% in cells transfected with non-targeting controls (Po0.001; Figure 3b ). Taken together, these results strongly indicate that inhibition of the miR-506-514 cluster increased apoptosis in these cell lines.
Inhibition of the miR-506-514 cluster significantly reduced soft agar colony formation In-vitro-transformed cells and cancer-derived cells are able to survive and grow in the absence of anchorage to an extracellular matrix. The ability to regulate this process may have a profound effect on tumor progression. Accordingly, we examined the effect of inhibiting the miR-506-514 cluster on the ability of melanoma cells to form colonies in soft agar. Figure 4 shows that inhibition of the miR-506-514 cluster in both A375 and SKMEL-5 cell lines reduced colony formation by 50% compared with non-targeting miRNA control (Po0.001). As the capacity for anchorage-independent growth represents one of the most important oncogenic properties of cancer cells, these data confirmed a functional role for the miR-506-514 cluster that is critical in maintaining the melanoma phenotype.
Inhibition of putative sub-cluster miR-506-507-508-513 had an equal or greater effect on multiple cancer functions than the full miR-506-514 cluster Physical distance mapping and analysis of the phylogenetic relationships of the miR-506-514 cluster members suggested a clear separation of the miRNAs within this cluster into two smaller putative sub-clusters (Zhang et al., 2007; Li et al., 2010) , which we have termed sub-cluster A, consisting of miRs-506, -507, -508-3p, -508-5p, -513-a-3p, -513-a-5p, -513-b and -513-c, and sub-cluster B, consisting of miRs-509-3p, -509-5p, -510 and -514. It is possible that the miR-506-514 cluster could be further divided into smaller sub-clusters, where miR-513-a-3p, -513-a-5p, -513-b, -513-c; miR-509-3p, -509-5p; and miR-510, -514 would comprise three other possible sub-clusters ( Figure 5 ). In order to investigate the effect of these putative sub-clusters on melanoma growth, members of each sub-cluster, at a final concentration of 70 nM divided equally among the number of members included, were inhibited in multiple cell lines. Cell growth was measured 3 and 5 days posttransfection. Figure 6a shows the day 5 growth results, which revealed that the miR-506-507-508-513 sub-cluster (sub-cluster A) had an equal or greater effect on inhibiting cell growth as the full cluster. In contrast, inhibition of sub-cluster B had a minimal effect on melanoma cell growth that was much less than the full cluster or sub-cluster A ( Figure 6a ). Multiple smaller combinations of the miR-506-514 cluster were also examined, as was each miRNA individually, but no combination evaluated was able to produce the same effect as the full cluster or sub-cluster A ( Figure 6a and Supplementary Figure 1) . Additionally, removing any member of sub-cluster A altered its functional effects (Supplementary Figure 1) , which emphasizes that all four members of this sub-cluster are necessary for maintaining the melanoma phenotype. Similarly, the effect of inhibiting these putative sub-clusters on melanoma cell invasion and migration was examined using MALME-3M and A375 cells. We found that only inhibition of sub-cluster A reduced invasion and migration equal to or greater than the level observed following inhibition of the full cluster ( Figure 6b ). The effect observed following inhibition of sub-cluster A was seen at both 6 and 24 h, but was not seen by inhibiting sub-cluster B (Figure 6b ).
To measure apoptosis, we utilized caspase 3/7 activation and Annexin V flow cytometry assays. Results showed that caspase activation was increased to an equal or greater level by sub-cluster A as seen with the full cluster ( Figure 7a ). Furthermore, the Annexin V/PI flow cytometry assay confirmed the caspase activation data and indicated that inhibiting sub-cluster A in three melanoma cell lines increased the percentage of early and late apoptotic cells (Annexin V positive/PI negative and Annexin V positive/PI positive, respectively) equal or greater than that seen with the full cluster (Figure 7b ). This was not observed with sub-cluster B (Figure 7b ) and no other sub-cluster combinations tested had a similar effect ( Supplementary  Figure 2) . Figure 2 Inhibition of the miR-506-514 cluster potently affected melanoma cell growth and invasion/migration. Melanoma cell lines and primary melanocytes were seeded and transfected 24 h later with 10 nM of anti-miR to each cluster member or a non-targeting control using PrimeFect siRNA transfection reagent. Transfection efficiency of 80-85% was achieved for all cell lines, as measured with a fluorescently labeled miRNA inhibitor (Dharmacon). (a) Cell growth, as measured by Cell Titer-Glo (CTG), was evaluated 3 and 5 days post-transfection (day 3 is shown). Results are presented as percentage of inhibition of growth relative to non-targeting control (set to 0%) across four independent experiments. * indicates a statistically significant difference between melanoma cell lines and normal melanocytes, Po0.001. (b) At 24 h after transfection, 50 000 MALME-3M or A375 cells were seeded into each chamber of a 96-well Cultrex dish, coated with basement membrane extract for invasion or uncoated for migration. After 6 h or 24 h, migrated or invaded cells were stained with Calcein-AM and quantified by measuring fluorescence. Results are shown as percentage of inhibition of invasion or migration relative to non-targeting control (set to 0%) across four independent experiments. * indicates a statistically significant difference between cells transfected with miR-506-514 inhibitors vs non-targeting control, Po0.001.
Novel oncogenic role for miRNA-506-514 cluster in melanoma KL Streicher et al Finally, inhibition of sub-cluster A in A375 and SKMEL-5 cells significantly reduced colony formation in soft agar to levels seen following inhibition of the full cluster (Po0.001, Figure 8 ). Given that the phenotypic effects regulated by the full miR-506-514 cluster and sub-cluster A are both statistically significant and nearly identical, we can conclude that sub-cluster A has an essential role in modulating pathways important for melanoma growth and progression.
Overexpression of the miR-506-514 full cluster transformed normal melanocytes In addition to investigating the role of the miR-506-514 cluster in controlling melanoma cell growth, apoptosis and invasion, we examined its oncogenic capabilities by transfecting normal melanocytes with miRNA mimics of each member of the full miR-506-514 cluster or subcluster A, sub-cluster B or non-targeting mimic control. miRNA mimics were transfected at 10 nM each or at equal individual concentrations totaling 120 nM. We evaluated cell growth (Cell titer-glo, CTG) on days 1, 3, 6, and 8 post-transfection, but no differences were observed in this in vitro assay (Supplementary Figure 3) . In contrast, overexpression of the full cluster, but not sub-clusters A or B, was able to induce melanocyte transformation, as indicated by a 30-fold increase in colony number relative to melanocytes transfected with non-targeting mimic control (Po0.001, Figure 9 ). To assess changes in gene expression associated with anchorage-independent growth, we isolated RNA from the melanocyte colonies that grew in soft agar and examined a panel of melanoma and cancer-specific markers by TaqMan reverse transcriptase PCR (Figure 10 ). Consistent with expectation (Hoek et al., 2004; Kuphal et al., 2006; Klein et al., 2007; Palmieri et al., 2009; Bandarchi et al., 2010) , miR-506-514 overexpression and growth in soft agar was associated with substantial downregulation of E-cadherin, P-cadherin, p16/CDKN2A, DKK3, RAB33A, TYRP1 and BAD, as well as greatly increased expression of Ki67, MIA, DCT and the stem cell markers PROM1/ CD133 and Nestin. Other genes showed no changes in expression due to altered miR-506-514 levels.
Discussion
The first reports linking altered expression of a single miRNA to a function in melanoma tumorigenesis and conducting detailed comparisons of the miRNA profiles Novel oncogenic role for miRNA-506-514 cluster in melanoma KL Streicher et al of normal melanocytes and melanoma cell lines have only recently been published (Felicetti et al., 2008; . The ability of miR-221 and miR-222 to regulate the c-Kit receptor (Felicetti et al., 2008) , miR-let-7b to inhibit cell-cycle progression (Schultz et al., 2008) and miR-193b to induce cell-cycle arrest by altering CCND1 (Chen et al., 2010 ) illustrate a few studies that contain functional experiments linking miRNA alterations to melanoma development/progression. However, the potential roles for miRNAs as diagnostic biomarkers or as targets have yet to be investigated fully in melanoma. In this study, we focused on a novel miRNA cluster, miR-506-514, which is consistently overexpressed in both melanoma skin punches and melanoma cell lines relative to normal skin and melanocytes. Results revealed that this miRNA cluster is a transforming oncogene that regulates key melanoma pathways. Melanoma is a highly metastatic Figure 4 Inhibition of the miR-506-514 cluster transformed primary melanocytes to grow in soft agar. The A375 and SKMEL-5 melanoma cell lines were seeded and transfected 24 h later with 10 nM of anti-miR to each cluster member or a non-targeting control (NTC) using Primefect siRNA transfection reagent. After 30 h, cells were trypsinized and 25 000 cells were combined with 0.3% agar. The 0.3% agar/cell mixture was seeded on top of a layer of 0.5% agar, previously added to each well of a six-well plate and allowed to solidify for 30 min. After 3 weeks of growth, colonies were (a) photographed at Â 10 magnification using the Nikon TE2000 microscope and (b) stained with CyQuant to fluorescently measure viable colonies in quadruplicate wells from three separate experiments. * indicates a statistically significant difference between cells transfected with the full cluster compared with cells transfected with NTC, Po0.001.
cancer, which contributes to its high mortality rate. The involvement of this novel miRNA cluster in the invasive and migratory capabilities of melanoma suggests that it may regulate primary tumor growth, as well as metastatic progression. Furthermore, all members of the miR-506-514 cluster are required to initiate cancer formation, but maintaining cancer growth and preventing apoptosis may be distinctly regulated by only a subset of miRNAs (sub-cluster A). Discovering downstream targets of the miR-506-514 cluster may reveal pathways that explain the multi-functional role of this novel cluster in contributing to both the initiation and maintenance of melanoma. Although the oncogenic role of this cluster in melanoma is a new finding, individual members of this cluster have been shown previously to be overexpressed in melanoma cell lines . Specifically, found that miR-506 and miR-507 were upregulated in primary tumor cell lines compared with normal melanocytes. They also utilized a MIAdeficient melanoma cell line-representing a shift from melanoma cells to melanocytes-and found that miR-506, miR-507 and miR-514 were downregulated during this transition ). Both observations are consistent with our results and with the potential for this cluster to have a key role in melanoma progression. Our results identified miR-506 and miR-507 as members of sub-cluster A, which we showed to be the key component of the miR-506-514 cluster that is responsible for maintaining the cancer phenotype. Interestingly, miR-506 and miR-507 were also shown to be downregulated in metastatic colonization, despite the observed upregulation during early progression ). It is not clear why these miRNAs may decrease during metastatic colonization; however, data from our study on the functions of sub-cluster A versus the full miR-506-514 cluster support shifting roles for various members of this cluster depending on the stage of cancer progression. Continued work on identifying the mechanism behind the stage-specific expression of this cluster could potentially make it a valuable prognostic or diagnostic biomarker.
In characterizing the function of this novel miRNA cluster and its sub-clusters, we discovered that it has a critical role in regulating cell growth (Figures 2a and  6a) , apoptosis (Figures 3 and 7) , invasion (Figures 2b  and 6b ) and soft agar colony formation (Figures 4 and  8) , which are all representative of the multi-step process of cancer progression. Furthermore, our study revealed that this cluster is sufficient for melanocyte transformation and alters the expression of many genes known to be involved in the development of melanoma specifically, and cancer in general (Figure 10 ). This is not the first miRNA cluster identified to have oncogenic Novel oncogenic role for miRNA-506-514 cluster in melanoma KL Streicher et al Novel oncogenic role for miRNA-506-514 cluster in melanoma KL Streicher et al properties in cancer. The oncogenic miRNA clusters miR-17-92 and miR-106a-363 are upregulated in primary tumor cell lines, with miR-17-92 further increased in metastatic cell lines (Landais et al., 2007; Olive et al., 2010) . The miR-15a-miR-16-1 cluster has a tumor-suppressor role in prostate cancer, regulating genes important for cancer cell survival, proliferation and invasion (Bonci et al., 2008) . Like the miR-17-92 and miR-106a-363 clusters, miR-106b-25 was shown to be proto-oncogenic in prostate cancer through its cooperation with PTEN loss to confer transformation (Poliseno et al., 2010) .
The oncogenic role for the miR-506-514 cluster in melanoma is similar to others previously identified, but unique due to its role both in melanoma progression and melanocyte transformation. Overexpression of the miR-506-514 cluster had a substantial impact on anchorageindependent growth as measured by colony formation in soft agar, but did not alter in vitro proliferation. Oncogenes have been demonstrated to have specific effects on various aspects of cancer progression (Dykxhoorn et al., 2009 ) and the effect on soft agar colony formation can be greater than the effect on in vitro proliferation (Nakamura et al., 2008; Chin et al., Figure 8 miR-506-507-508-513 sub-cluster inhibition in melanoma cell lines reduced soft agar colony formation equal to full miR-506-514 cluster. Melanoma cell lines were seeded and transfected 24 h later with 10 nM of anti-miR to each cluster member or a non-targeting control (NTC) using Primefect siRNA transfection reagent. After 30 h, cells were trypsinized and 25 000 cells were combined with 0.3% agar. The 0.3% agar/cell mixture was seeded on top of a layer of 0.5% agar, previously added to each well of a six-well plate and allowed to solidify for 30 min. After 3 weeks of growth, colonies were (a) photographed at Â 10 magnification using the Nikon TE2000 microscope and (b) stained with CyQuant to fluorescently measure viable colonies in quadruplicate wells from three separate experiments. * indicates a statistically significant difference between cells transfected with the full cluster compared to cells transfected with NTC, Po0.001.
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; Hartman et al., 2011) . Moreover, many previous publications have utilized the soft agar assay to demonstrate the transformation capacity of oncogenes (Rasmussen et al., 2001; Lu et al., 2008; Syed et al., 2008; Monsel et al., 2010) , as this assay is well documented to be predictive of in vivo tumorigenicity (Rhim, 1983; Trainer et al., 1988) , malignant potential (Montesano et al., 1977) and drug response (Zirvi et al., 1983; Scholz et al., 1990) . Taken together, these observations increase confidence in the oncogenic potential of the miR-506-514 cluster. Additionally, as melanocyte transformation is a complicated process typically requiring more than one cellular alteration, our results suggest that this miRNA cluster simultaneously affects multiple pathways critical for melanoma development.
Analysis of DNA sequence upstream of the miR-506-514 cluster did not reveal strong binding sites for transcription factors relevant to cancer, suggesting a novel mechanism for upregulation of this miRNA cluster. Gene expression changes induced during melanocyte transformation may provide a clue. Based on alterations observed in melanocytes growing in soft agar, it is clear that the miR-506-514 cluster is upstream of multiple pathways contributing to cancer development, such as cell growth (p16/CDKN2A, RAB33a, Ki67), suppression of apoptosis (BAD), cell migration and invasion (E-cadherin, N-cadherin, MIA, P-cadherin), and acquisition of stem cell properties (NES, PROM1/CD133). Further work will be needed to understand if expression of this cluster is regulated by transcription factors implicated in these pathways.
In order to further examine the mechanism of action of the miR-506-514 cluster, we generated a list of over 1000 predicted targets that were identified using three different miRNA target prediction algorithms and Figure 9 Overexpression of the miR-506-514 cluster transformed primary melanocytes to grow in soft agar. Melanocytes were seeded and transfected with 120 nM of miRNA mimics for the miR-506-514 cluster or indicated sub-clusters, as described. After 30 h, cells were trypsinized and 25 000 cells were combined with 0.3% agar. The 0.3% agar/cell mixture was seeded on top of a layer of 0.5% agar, previously added to each well of a six-well plate and allowed to solidify for 30 min. After 3 weeks of growth, colonies were (a) photographed at Â 10 magnification using the Nikon TE2000 microscope and (b) counted in 3 fields per well in quadruplicate wells from three separate experiments using Nikon software. * indicates a statistically significant difference between cells transfected with the full cluster compared with cells transfected with non-targeting mimic control, Po0.001.
focused on genes involved in biological pathways aligned with our observations, that is cell proliferation, apoptosis, invasion and cell transformation. The largely non-overlapping lists of targets predicted by these algorithms supports our notion that the strong oncogenic role of the miR-506-514 cluster in melanoma is perhaps due to its capacity for widespread gene regulation in a myriad of molecular networks. The lack of overlap in predicted targets also makes the identification of biologically relevant target genes for the miR-506-514 cluster a daunting task, which may become easier as technology improves and we develop more sophisticated bioinformatic tools to distinguish true targets from false positives. Preliminary analyses have yet to identify direct downstream targets of the cluster, but of particular interest for evaluation at the protein level are members of developmental pathways, including the Notch ligands JAG1 and JAG2 and the Wnt pathway antagonist DKK3, due to the tumor suppressor role identified for these pathways in melanoma (Kuphal et al., 2006; Dotto, 2008; Osawa and Fisher, 2008) . The specific decrease in DKK3 observed following overexpression of the miR-506-514 cluster suggests that it may have a mechanistic role in mediating the actions of this cluster in melanoma. Understanding the full molecular mechanism downstream of the miR-506-514 cluster may considerably increase our fundamental understanding of melanomagenesis.
Overexpression of the miR-506-514 cluster in nearly all melanoma samples tested suggests that it could have utility as a diagnostic or prognostic biomarker.
Follow-up studies incorporating a large sample size comprised of benign nevi, melanoma tissue from various stages of development, as well as metastatic tumors would be necessary to determine the critical timing of over-expression of miR-506-514 cluster and its association with melanoma stage. Additionally, future work will focus on uncovering potential reasons for the induction of this miRNA cluster in melanoma. Given the role of the miR-506-514 cluster in melanocyte transformation, it may be an early event critical for the shift from benign nevi to an early melanoma and therefore could be a critical biomarker with the potential to enable earlier diagnosis and inform treatment decisions. Tumor-associated miRNA patterns have been shown to be highly tissue specific (Ha¨usler et al., 2010) and very stable in tissue, blood and in formalin-fixed, paraffin-embedded tissue, hence information about altered miRNA levels could be obtained from multiple sources and quantified by standard methods at any time during the course of the disease (Segura et al., 2010) . A proof-of-principle study was recently conducted to examine whole-blood miRNA profiles for identifying ovarian cancer or monitoring its relapse (Osawa and Fisher, 2008; Leidinger et al., 2010) . Although the study was small, the preliminary positive results in identifying a subset of miRNAs consistently and specifically altered in individuals with ovarian cancer supports the future clinical utility of altered miRNA signatures (Ha¨usler et al., 2010) . With the existing limitations in the current melanoma staging system, as well as the inability to identify early neoplastic cells or differentiate melanomas that are likely to metastasize, it is clear that the addition of a molecular marker predictive of these features would provide profound clinical benefit to melanoma patients.
Materials and methods
Patients and controls
A total of 33 malignant melanoma skin biopsies and 14 normal skin biopsies were obtained from ILSBio (Chestertown, MD, USA). Melanoma samples were from both female and male Caucasian patients, ages 26-81, and included stages IIB to IV. In all 23 of 33 melanoma patients had documented metastases to various areas of the body. Normal skin samples were obtained from healthy donors and a pooled value of all 14 normals was used for comparative analyses.
Real time quantitative reverse transcriptase PCR To isolate miRNA from skin biopsies and cultured cells, the mirVana miRNA Isolation kit was used according to the manufacturer's protocol (Applied Biosystems/Ambion, Austin, TX, USA). Relative fold change for each individual member of the miR-506-514 cluster was determined using TaqMan Low-Density Array (TLDA) microRNA Cards v 2.0 (Applied Biosystems, Foster City, CA, USA) or the BioMark Dynamic Array microfluidics system (Fluidigm Corporation, San Francisco, CA, USA). Single-stranded cDNA synthesis from 500 ng of total miRNA-RNA and pre-amplification of specific miRNA targets was performed according to the manufacturer's protocol. The microRNA TLDA cards were Figure 10 Markers involved in melanoma development and progression are altered following miR-506-514 cluster overexpression and melanocyte transformation. Following growth of melanocytes transfected with 120 nM miRNA mimics for the full miR-506-514 cluster, colonies were recovered from soft agar and RNA was isolated. Gene expression was measured by TaqMan reverse transcriptase PCR (Biomark dynamic array) for a panel of genes of known functional importance in melanogenesis. Average fold changes in transformed melanocytes from three independent experiments were determined by comparing gene expression levels with the average of three reference genes (ACTB, GAPDH, UBC) and then to the expression in normal melanocytes. * indicates a statistically significant difference between melanocytes transformed to grow in soft agar compared with normal melanocytes, Po0.001.
loaded and run on an Applied Biosystems 7900HT Real-Time PCR system. Fluidigm arrays were loaded as described by the manufacturer and the BioMark Real-Time PCR System was used for thermal cycling. All TaqMan primer/probes used in this manuscript were inventoried assays obtained from Applied Biosystems.
Data analysis of the resulting Ct values was conducted with SDS v2.2.2 software (Applied Biosystems) or BioMark analysis software (Fluidigm Corporation). All samples were normalized to the mean Ct value of several calibrator genes (U6, RNU44, RNU48, RNU6B) and then a pooled DCt value from normal skin or a DCt value in normal melanocytes was used to calculate relative fold change levels in the tissue and in cell lines.
Cell culture Cells used in this study were as follows: A375, SKMEL-2, SKMEL-5, Malme-3M and RPMI-7951 melanoma cell lines, as well as primary epidermal melanocytes. All cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultivated in recommended media at 37 1C in a humidified atmosphere with 5% CO 2 .
Melanocytes were derived from four unique donors. They were passaged once before performing experiments or collecting RNA and were not used beyond passage 8.
Transfection reagents and conditions miRIDIAN microRNA hairpin inhibitors and negative controls, as well as miRIDIAN microRNA mimics and negative controls were purchased from Dharmacon (Lafayette, CO, USA). PrimeFect siRNA Transfection Reagent (Lonza, Walkersville, MD, USA) was used for all transfections, according to the manufacturer's guidelines. Transfection efficiency for all cell lines was determined by utilizing Dy-547-labeled miRNA mimic or inhibitor controls (Dharmacon).
Melanoma cells were transfected with either 10 nM of each appropriate miRNA hairpin inhibitor or a final combined concentration of 70 nM (divided equally among the number of inhibitors examined) or 70 nM of the inhibitor negative control. Primary melanocytes were transfected with either 10 nM of each appropriate miRNA mimic or 120 nM of the mimic negative control. Each isoform identified for a particular mature miRNA mimic was included in the transfection.
Cell growth
Cell growth was measured 3 and 5 days post-transfection with inhibitors to the full cluster, sub-cluster A, sub-cluster B or negative control using the Cell Titer-Glo Luminescent Cell Viability Assay (CTG; Promega, Madison, WI, USA) according to the manufacturer's protocol. Luminescent data were collected on the EnVision Plate Reader (Perkin Elmer, Waltham, MA, USA).
Apoptosis
Caspase activation was measured following transfection with inhibitors to the full cluster, sub-cluster A, sub-cluster B or negative control using the Caspase-Glo 3/7 Assay (Promega) according to the manufacturer's protocol. Luminescence data were collected on the EnVision Plate Reader (Perkin Elmer).
Apoptosis also was measured using the Vybrant Apoptosis Assay Kit #2 with Alexa Fluor 488 Annexin V/PI (Invitrogen, Carlsbad, CA, USA). Transfected cells were incubated with Annexin V and PI, according to the manufacturer's protocol. As a positive control, non-transfected cells were treated overnight with 250 nM staurosporine (Sigma, St Louis, MO, USA). Samples were analyzed by flow cytometry using a BD LSR II flow cytometer (BD Biosciences, San Jose, CA, USA) and results were evaluated using FlowJo analysis software (Tree Star, Inc., Ashland, OR, USA). Percentages of Annexin V positive/PI negative and Annexin V positive/PI positive cells were quantified and compared with untreated and nontargeting miRNA controls.
Invasion and migration
Cell invasion and migration assays were performed using Cultrex 96-well BME Cell Invasion or Cell Migration Boyden chambers (Trevigen Inc., Gaithersburg, MD, USA). Briefly, Malme-3M and A375 cells were transfected with inhibitors to the full cluster, sub-cluster A, sub-cluster B or negative control, and then seeded 24 h later into the upper chamber of the Cultrex dish in serum-free media. For invasion, the chamber was coated with 0.25 Â basement membrane extract; for migration, the chamber was uncoated. After 6 or 24 h, cells that invaded or migrated were dissociated and stained with Calcein-AM according to the manufacturer's protocol. Fluorescence was measured at 485 nm excitation/520 nm emission using the SpectraMax M5 (Molecular Devices, Sunnyvale, CA, USA) to quantify invading/migrating cell numbers.
Soft agar colony formation
Melanoma cell lines or primary melanocytes were transfected as described for 30 h. A total of 25 000 cells were combined with 0.3% agar and seeded onto a layer of 0.5% agar. After 3 weeks of growth, colonies were photographed using a Nikon TE200 microscope (Nikon Instruments, Melville, NY, USA), then either counted in 3 fields per well in quadruplicate wells or quantified using the CytoSelect Cell Transformation Assay kit (Cell Biolabs, San Diego, CA, USA) according to manufacturer's instructions. Briefly, matrix solubilization solution was added to solubilize the agar, then cells were incubated with CyQuant GR Dye (Cell Biolabs). Viable cells were measured fluorescently in quadruplicate wells for each condition.
Statistical analysis
Statistical comparisons were conducted using the Welch two-sample t-test; Po0.05 was considered significant.
